2009
DOI: 10.1590/s0001-37652009000300008
|View full text |Cite
|
Sign up to set email alerts
|

Portal hypertensive response to kinin

Abstract: Portal hypertension is the most common complication of chronic liver diseases, such as cirrhosis. The increased intrahepatic vascular resistance seen in hepatic disease is due to changes in cellular architecture and active contraction of stellate cells. In this article, we review the historical aspects of the kallikrein-kinin system, the role of bradykinin in the development of disease, and our main findings regarding the role of this nonapeptide in normal and experimental models of hepatic injury using the is… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 69 publications
0
4
0
Order By: Relevance
“…Similar protective effects were observed in cardiac, renal and liver damage models [36]. For instance, B2 activation induces a hypertensive hepatic response [37], which could play a role in malaria liver stage physiology, with modulation of hepatic blood flow and parasite distribution in the tissue.…”
Section: Discussionmentioning
confidence: 61%
“…Similar protective effects were observed in cardiac, renal and liver damage models [36]. For instance, B2 activation induces a hypertensive hepatic response [37], which could play a role in malaria liver stage physiology, with modulation of hepatic blood flow and parasite distribution in the tissue.…”
Section: Discussionmentioning
confidence: 61%
“…Kinin B1R is an important inflammatory mediator and is correlated to the hemodynamic response to kinins, with increased blood pressure induced by des-Arg 9 -bradykinin [42, 43]. In hepatic perfusion, BK induces a portal hypertensive response that is mediated by B2R and modulated by NO system in healthy liver, as well as, in inflammatory, fibrotic, and cirrhotic conditions [28]. The B1R and B2R antagonists promote downregulation of pro-inflammatory molecules and upregulation of anti-inflammatory molecules, representing a new therapeutic strategy for the prevention and treatment of renal ischemia-warm reperfusion injury [44].…”
Section: Discussionmentioning
confidence: 99%
“…The hepatic microcirculation can be modulated by the kinin-signalling pathway through activation of B1 or B2 kinin receptors resulting in a portal hypertensive response [28]. Both receptors are coupled to G protein, but the B2R is constitutively expressed, whereas the B1R expression is inducible by inflammatory cytokines in different tissues such as smooth muscle cells, endothelial cells, human sinusoidal cells from fibrotic liver and others [27, 29, 30].…”
Section: Introductionmentioning
confidence: 99%
“…However, studies have indicated that action of bradykinin is not limited to these receptors, so possible anti-inflammatory effects of carboxypeptidase inhibition are controversial and should be tested separately. 44 …”
Section: Introductionmentioning
confidence: 99%